Table 2.

Liver and Spleen stiffness measurement decreases after sustained viral response

Variable	Overall (n = 134)	CSPH (LSM ≥ 21 kPa) (n = 60)	No CSPH (LSM < 21 kPa) (n = 74)
Relative SSM decrease (%)	12.3 (0-36.3)	4.7 (0-32.5)	20.4 (0-39.7)
Overall SSM decrease	92 (68.7)	40 (66.7)	52 (70.3)
> 10%	73 (54.5)	31 (51.7)	42 (56.8)
> 20%	60 (44.8)	23 (38.3)	37 (50)
Relative LSM decrease (%)	30 (13.5-42.4)	28.3 (11.4-41.9)	30.8 (13.9-42.4)
Overall LSM decrease	114 (85.1)	51 (85)	63 (85.1)
> 10%	108 (80.6)	48 (80)	60 (81.1)
> 20%	88 (65.7)	40 (66.7)	48 (64.9)
PLT Increase (%)	12.4 (-10.1 to 29.6)	5.5 (-15.6 to 25.9)	17.4 (-0.67 to 35.6)

CSPH: Clinically significant portal hypertension; LSM: Liver stiffness measurement; PLT: Platelet count; SSM: Spleen stiffness measurement.